<DOC>
	<DOCNO>NCT00278642</DOCNO>
	<brief_summary>Autoimmune Bullous Skin Disorders believe due immune cell , cell normally protect body causing damage body . This study design examine whether treat patient high dose cyclophosphamide ( drug reduces function immune system ) together anti-thymocyte globulin ( protein kill immune cell think cause disease ) , follow return previously collect special blood cell ( stem cell ) result improvement disease . Stem cell undeveloped cell capacity grow mature blood cell , normally circulate blood stream . The purpose intense chemotherapy destroy cell immune system may cause skin disease . The purpose stem cell infusion restore body 's blood production , severely impaired high dose chemotherapy anti-thymocyte globulin .</brief_summary>
	<brief_title>Hematopoietic Stem Cell Support Patients With Autoimmune Bullous Skin Disorders</brief_title>
	<detailed_description />
	<mesh_term>Pemphigus</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<criteria>1 . Less chronologic age 60 year time pretransplant evaluation . 2 . An establish diagnosis autoimmune skin disorder include follow : 1. pemphigus vulgaris 2. pemphigus foliaceus Diagnosis bullous skin lesion base history physical , skin biopsy ( light microscopy indirect fluorescence ) , indirect immunofluorescence titer , BP 180 230 titer , Desmolglein3 Desmoglein1 antibody , photograph . 3 . Patients fail corticosteroid ( equivalent dosage prednisone 0.5 mg/kg/day 3 month ) , least two follow : azathioprine , mycophenolate mofetil , gold , tetracycline ( minocycline ) , cyclosporin , methotrexate , gold , plasmapheresis . Failure define inability wean steroid le 0.5 mg/kg/day . 4 . Potential candidate must involvement 10 % skin body surface area , involvement one mucosal lesion , recurrent infection require two hospitalization source infection due bullous skin disease . 5 . All candidate must evaluate two dermatologist , Dr. Joan Guitart Dr. Joaquin Brieva , must concur patient refractory disease may , clinical judgement , associate 510 % mortality control . 6 . A minimum 2.0 x 106 CD34+ cells/kg selection necessary proceed transplant . 1 . Individuals le 18 year age . 2 . Significant end organ damage : 1 . LVEF &lt; 40 % deterioration LVEF exercise test MUGA echocardiogram . 2 . Untreated lifethreatening arrhythmia . 3 . Active ischemic heart disease heart failure . 4 . DLCO &lt; 45 % FEV1/FEV &lt; 50 % . 5 . Serum creatinine &gt; 2.5 mg/dl . 6 . Liver cirrhosis , transaminases &gt; 3x normal limit bilirubin &gt; 2.0 unless due Gilberts disease . 3 . HIV positive . 4 . Uncontrolled diabetes mellitus , illness opinion investigator would jeopardize ability patient tolerate aggressive treatment . 5 . Prior history malignancy except localize basal cell squamous skin cancer . Other malignancy patient judge cured local surgical therapy , ( limit ) head neck cancer , stage I II breast cancer consider individual basis . 6 . Positive pregnancy test , inability unable pursue effective mean birth control , failure willingly accept comprehend irreversible sterility side effect therapy . 7 . Psychiatric illness mental deficiency make compliance treatment inform consent impossible . 8 . Inability give inform consent . 9 . Major hematological abnormality platelet count less 100,000/ul , ANC le 1000/ul . 10 . Presence infect skin lesion . All skin lesion free suppurative exudate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>